Yahoo · Feb 26, 2026
Medpace (MEDP) Rises As Market Takes a Dip: Key Facts
Medpace (MEDP) reached $447.09 at the closing of the latest trading day, reflecting a +2.06% change compared to its last close.
ME
NASDAQ · MEDP
Medpace Holdings, Inc.
Healthcare · Medical - Diagnostics & Research
$620.48
Up+$25.07 (+4.21%)
Updated Sep 16, 2026, 11:46 AM
SID Score
5.9/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 15.94B
- P/E ratio
- 37.95
- Dividend yield
- 0.00%
- 52-week range
- $373.00 – $677.90
- Volume
- 303.86K
- Avg. volume
- 309.53K
Price performance
MEDP price history
1M range · 0 trading sessions · Daily adjusted prices
MEDP does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest MEDP news
The latest Smart Investors Daily articles mentioning MEDP.
Stock researchCompany · Overview
MEDP research
Overview
Company profile and research snapshot.
Company profile
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $562.00
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jul 24, 2026 | Baird | Neutral | — |
| Jul 24, 2026 | RBC Capital | Outperform | — |
| Jul 24, 2026 | TD Cowen | Hold | — |
| Jul 24, 2026 | Truist Securities | Hold | — |
| Jul 24, 2026 | BMO Capital | Market Perform | — |
News briefing
No generated briefing is available yet.
Yahoo · Feb 25, 2026
Evaluating Medpace Holdings (MEDP) After A Sharp 27% One-Month Pullback
If you are wondering whether Medpace Holdings is still priced attractively after a strong multi year run, it helps to step back and look carefully at what the current share price implies about future expectations. The stock closed at US$438.08, with a 1.8% decline over the last week and a 27.2% decline over the last 30 days, although the 1 year return of 29.0% and 3 year return of 123.2% show a very different picture to the recent pullback. These moves have come against a backdrop where...
Benzinga · Feb 18, 2026
TD Cowen Upgrades Medpace Holdings to Hold, Lowers Price Target to $419
TD Cowen analyst Charles Rhyee upgrades Medpace Holdings (NASDAQ:MEDP) from Sell to Hold and lowers the price target from $462 to $419.
Yahoo · Feb 18, 2026
Here Are Wednesday’s Top Wall Street Analyst Research Calls: Cadence Design, Crox, Genuine Parts, Kratos Defense, Medtronic, Palantir, StubHub, Transocean, and More
Pre-Market Stock Futures: Futures are trading higher after a sluggish start to the holiday-shortened trading week. While stocks started as if it were going to be another risk-off day, they turned positive by late morning, and all the indices ended the day modestly higher. With a trove of economic data on the way, and fourth-quarter ... Here Are Wednesday’s Top Wall Street Analyst Research Calls: Cadence Design, Crox, Genuine Parts, Kratos Defense, Medtronic, Palantir, StubHub, Transocean, and Mo
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
